This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaulont, S Articles by Raymondjean, M Search for Related Content PubMed PubMed Citation Articles by Vaulont, S Articles by Raymondjean, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 October; 9(10): 4409-4415

Analysis by cell-free transcription of the liver-specific pyruvate kinase gene promoter.

Unité de Recherches en Génétique et Pathologie Moléculaires, INSERM U. 129-CHU Cochin, Paris, France.

ABSTRACT

A DNA fragment spanning nucleotides -183 to -4 with respect to the cap site of the rat L-type pyruvate kinase (L-PK) gene contains at least four binding sites for putative transcriptional factors: hepatocyte nuclear factor 1 (HNF1), liver factor A1 (LF-A1), nuclear factor 1 (NF1), and major late transcription factor (MLTF). This fragment was used to direct transcription of a reporter sequence (a G-free cassette) in cell extracts. This L-PK promoter was active in liver nuclear extracts, but not in extracts from nonhepatic tissues. A reduction of 50% of the activity was obtained with a deleted L-PK promoter containing only the HNF1-binding site. In contrast, deletion of the HNF1-binding site inactivated the promoter by more than 90%. These results were confirmed by titration experiments with synthetic oligonucleotides. Titration of HNF1 resulted in an 85% decrease of transcriptional activity, while titration of LF-A1 resulted in only a 40% decrease. The influence of NF1 and MLTF seemed to be marginal in this system. The proximal 5'-flanking sequence of the L-PK gene therefore appears to function in vitro as an efficient liver-specific promoter which requires the binding of the liver factor HNF1 and which is also stimulated by the binding of another liver-specific factor, LF-A1.

This article has been cited by other articles:

• Samoylenko, A., Roth, U., Jungermann, K., Kietzmann, T. (2001). The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. Blood 97: 2657-2666 [Abstract] [Full Text]  
• Mitanchez, D., Doiron, B., Chen, R., Kahn, A. (1997). Glucose-Stimulated Genes and Prospects of Gene Therapy for Type I Diabetes. Endocr. Rev. 18: 520-540 [Abstract] [Full Text]  
• Pao, C.-I, Lin, K.-w. M., Zhu, J.-l., Wu, G.-j., Farmer, P. K., Phillips, L. S. (1996). In Vitro Transcription of the Rat Insulin-like Growth Factor-I Gene. J. Biol. Chem. 271: 8667-8674 [Abstract] [Full Text]  
• Tian, J M, Schibler, U (1991). Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4.. Genes Dev. 5: 2225-2234 [Abstract]  
• Sladek, F M, Zhong, W M, Lai, E, Darnell, J E (1990). Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.. Genes Dev. 4: 2353-2365 [Abstract]